PT. Enam Delapan Sembilan
FDA import alert and refusal historyLamongan, IndonesiaFEI 3006441841
Recorded by FDA as PT. ENAM DELAPAN SEMBILAN
As of October 26, 2026, PT. Enam Delapan Sembilan (Lamongan, Indonesia) is on the red list of FDA Import Alert 16-81 (Seafood products: Salmonella) for scarlet snapper; tilapia, published by FDA on November 16, 2010, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-81 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for PT. Enam Delapan Sembilan
1 record, newest first. Each line links to the FDA page it came from.
2010
- Import alert listingListed on Import Alert 16-81red listScarlet Snapper; TilapiaSource
Questions about PT. Enam Delapan Sembilan
- Is PT. Enam Delapan Sembilan on an FDA import alert?
- Yes. As of October 26, 2026, PT. Enam Delapan Sembilan is on the red list of FDA Import Alert 16-81, “Seafood products: Salmonella”, for scarlet snapper; tilapia; FDA published the listing on November 16, 2010.
- Has FDA refused shipments from PT. Enam Delapan Sembilan?
- No FDA import refusals for PT. Enam Delapan Sembilan appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is PT. Enam Delapan Sembilan's FEI number?
- PT. Enam Delapan Sembilan's FDA Establishment Identifier (FEI) is 3006441841.
- Can shipments from PT. Enam Delapan Sembilan still enter the U.S.?
- Shipments of scarlet snapper; tilapia from PT. Enam Delapan Sembilan can be detained without physical examination under Import Alert 16-81; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from PT. Enam Delapan Sembilan?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.